Lucid Diagnostics Inc (NAS:LUCD)
$ 1.065 +0.050 (+4.85%) Market Cap: 203.17 Mil Enterprise Value: 215.10 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 26/100

Q3 2025 Lucid Diagnostics Inc Earnings Call Transcript

Nov 12, 2025 / 01:30PM GMT
Release Date Price: $1.11 (+6.73%)

Key Points

Positve
  • Lucid Diagnostics Inc (LUCD) is actively working to lay the groundwork for a growth phase.
  • The company is focused on securing Medicare coverage, which could significantly boost its growth prospects.
  • Lucid Diagnostics Inc (LUCD) encourages stakeholders to stay informed through various channels, indicating transparency and open communication.
  • The leadership, including Chairman and CEO Lishan Aklog, is directly involved in communicating the company's strategy and progress.
  • The company is proactive in engaging with its audience, inviting questions and feedback.
Negative
  • The earnings call did not provide specific financial metrics or performance data for the quarter.
  • There is uncertainty regarding the timeline for securing Medicare coverage, which is crucial for the company's growth.
  • The call lacked detailed information on current operational challenges or market conditions.
  • No new product developments or innovations were discussed during the call.
  • The call concluded without addressing potential risks or competitive pressures facing Lucid Diagnostics Inc (LUCD).
Lishan Aklog
Lucid Diagnostics Inc - Chairman and Chief Executive Officer

Specific ways we are working to lay the groundwork for a growth phase once we secure Medicare coverage. So hopefully that was clear. So again with that we appreciate your time. We encourage you to keep abreast of our progress. Please follow our news releases, follow-up on these calls as well as through our website and social media, and feel free to. Reach out to us if you have any specific, additional questions. So thanks again and everybody have a great day.

Operator

Thank you. Ladies and gentlemen, this concludes today's conference call.

Thank you for your participation. You may now disconnect.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot